Nuzenio

Drug Approval By

Drug Approval By news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 20 publisher sources 100/100 entity strength

Latest news

Scholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMT Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMT Eli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOXLiveNOW from FOX · Fri, 07 Aug 2026 15:20:40 GMT FDA Completes First-Cycle Review of Preservative-Free - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:00:00 GMT Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - NPRNPR · Fri, 07 Aug 2026 10:00:00 GMT ‘Concerning’ Trends in Cancer Drug Approvals - MedscapeMedscape · Fri, 07 Aug 2026 09:40:52 GMT FDA Approves Replimune’s Melanoma Drug on Third Attempt - WSJWSJ · Thu, 06 Aug 2026 21:48:37 GMT US FDA approves Replimune's skin cancer drug after prior rejections - ReutersReuters · Thu, 06 Aug 2026 21:30:41 GMT

Timeline

Sat, 08 Aug 2026 02:32:33 GMTScholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD

Fri, 07 Aug 2026 19:33:00 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron's

Fri, 07 Aug 2026 15:20:40 GMTEli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOX

Fri, 07 Aug 2026 11:00:00 GMTFDA Completes First-Cycle Review of Preservative-Free - GlobeNewswire

Fri, 07 Aug 2026 10:00:00 GMTKalshi and Polymarket bets on clinical trials criticized as 'ghastly' - NPR

Fri, 07 Aug 2026 09:40:52 GMT‘Concerning’ Trends in Cancer Drug Approvals - Medscape

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

FDA24 live mentions Replimune11 live mentions Moderna6 live mentions Takeda6 live mentions LiveNOW4 live mentions First4 live mentions Barron3 live mentions BioPharma Dive BioPharma3 live mentions Dive3 live mentions The Business Journals3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Drug Approval By.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

20 distinct publisher/source names are currently connected to this entity page.